Endothelial progenitor cells with Alzheimer's disease

Chinese Medical Journal

Volumn 124, Issue 6, 2011, Pages 901-906

  Kong, Xiao Dong ^a   Zhang, Yun ^a   Liu, LI ^a,b,c   Sun, Ning ^a   Zhang, Ming Yi ^a   Zhang, Jian Ning ^a,b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Neurological Institute   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Alzheimer's disease; Endothelial progenitor cells; Vascular dementia

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD FLOW VELOCITY; BRAIN ARTERY; CD34 SELECTION; CELL ASSAY; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PATHOGENESIS;

AGED; ALZHEIMER DISEASE; ANTIGENS, CD; ANTIGENS, CD34; DEMENTIA, VASCULAR; ENDOTHELIAL CELLS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; PEPTIDES; STEM CELLS;

EID: 79952824280     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.06.018     Document Type: Article

References (28)

1. Qiu J. Ticking time bomb faced by China's ageing population. Lancet Neurol 2007; 6: 582-583.
2. Zhang ZX, Zahner GE, Roman GC, Liu J, Hong Z, Qu QM, et al. Dementia subtypes in China: prevalence in Beijing, Xi'an, Shanghai, and Chengdu. Arch Neurol 2005; 62: 447-453.
3. De la Torre JC. Alzheimer's disease prevalence can be lowered with non-invasive testing. J Alzheimers Dis 2008; 14: 353-359.
4. Lee ST, Chu K, Jung KH, Park HK, Kim DH, Bahn JJ, et al. Reduced circulating angiogenic cells in Alzheimer disease. Neurology 2009; 72: 1858-1863.
5. + progenitors. Blood 2004; 104: 2010-2019.
6. Liu L, Liu H, Jiao J, Liu H, Bergeron A, Dong JF, et al. Changes in circulating human endothelial progenitor cells after brain injury. J Neurotrauma 2007; 24: 936-943.
7. Winblad B, Fioravanti M, Dolezal T, Logina I, Milanov IG, Popescu DC, et al. Therapeutic use of nicergoline. Clin Drug Investig 2008; 28: 533-552.
8. Taguchi A. Vascular factors in diabetes and Alzheimer's disease. J Alzheimers Dis 2009; 16: 859-864.
9. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
10. Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-3112.
11. + cells identify a population of functional endothelial precursors. Blood 2000; 95: 952-958.
12. Rustemeyer P, Wittkowski W, Jurk K, Koller A. Optimized flow cytometric analysis of endothelial progenitor cells in peripheral blood. J Immunoassay Immunochem 2006; 27: 77-88.
13. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109: 2972-2975.
14. Taguchi A, Matsuyama T, Nakagomi T, Shimizu Y, Fukunaga R, Tatsumi Y, et al. Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment. J Cereb Blood Flow Metab 2008; 28: 445-449.
15. Taguchi A, Nakagomi N, Matsuyama T, Kikuchi TA, Yoshikawa H, Kasahara Y, et al. Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction. J Cereb Blood Flow Metab 2009; 29: 34-38.
16. Hamel E, Nicolakakis N, Aboulkassim T, Ongali B, Tong XK. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease. Exp Physiol 2008; 93: 116-120.
17. De la Torre JC. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease? Ann N Y Acad Sci 2000; 903: 424-436.
18. Khalil Z, LoGiudice D, Khodr B, Maruff P, Masters C. Impaired peripheral endothelial microvascular responsiveness in Alzheimer's disease. J Alzheimers Dis 2007; 11: 25-32.
19. Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 2005; 28: 202-208.
20. Kandimalla KK, Scott OG, Fulzele S, Davidson MW, Poduslo JF. Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein. PLoS One 2009; 4: e4627.
21. Benarroch E. Neurovascular unit dysfunction: a vascular component of Alzheimer disease? Neurology 2007; 68: 1730-1732.
22. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319.
23. Gentile MT, Vecchione C, Maffei A, Aretini A, Marino G, Poulet R, et al. Mechanisms of soluble beta-amyloid impairment of endothelial function. J Biol Chem 2004; 279: 48135-48142.
24. Dede DS, Yavuz B, Yavuz BB, Cankurtaran M, Halil M, Ulger Z, et al. Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease? J Am Geriatr Soc 2007; 55: 1613-1617.
25. Rhodin JA, Thomas TN, Clark L, Garces A, Bryant M. In vivo cerebrovascular actions of amyloid beta-peptides and the protective effect of conjugated estrogens. J Alzheimers Dis 2003; 5: 275-286.
26. Burdo JR, Chen Q, Calcutt NA, Schubert D. The pathological interaction between diabetes and presymptomatic Alzheimer's disease. Neurobiol Aging 2009; 30: 1910-1917.
27. Gama Sosa MA, Gasperi RD, Rocher AB, Wang AC, Janssen WG, Flores T, et al. Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. Am J Pathol 2010; 176: 353-368.
28. Nakajima M, Ogawa M, Shimoda Y, Hiraoka S, Iida M, Koseki H, et al. Presenilin-1 controls the growth and differentiation of endothelial progenitor cells through its beta-catenin-binding region. Cell Biol Int 2006; 30: 239-243.